Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso

The scale‐up of highly active antiretroviral therapy (HAART) has led to a significant improvement in survival of the HIV‐positive patient but its effects on health‐related quality of life (HRQOL) are less known and context‐dependent. Our aim was to assess the temporal changes and factors associated with HRQOL among HIV‐positive adults initiating HAART in Burkina Faso.

[1]  U. Unicef,et al.  Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .

[2]  R. Bunnell,et al.  Trends and predictors of quality of life among HIV-infected adults taking highly active antiretroviral therapy in rural Uganda , 2007, AIDS care.

[3]  黄亚明,et al.  Journal of the International AIDS Society , 2017 .

[4]  T. Perneger,et al.  The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. , 1998, Journal of clinical epidemiology.

[5]  J. Moatti,et al.  Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART , 2001, HIV clinical trials.

[6]  P. Duncan,et al.  Predictors of changes in health-related quality of life among men with HIV infection in the HAART era. , 2005, AIDS patient care and STDs.

[7]  F. Dabis,et al.  Rapid scaling-up of antiretroviral therapy in 10 000 adults in Côte d'Ivoire: 2-year outcomes and determinants , 2008, AIDS.

[8]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[9]  V. Ridde,et al.  NGO-provided free HIV treatment and services in Burkina Faso: scarcity, therapeutic rationality and unfair process , 2012, International Journal for Equity in Health.

[10]  A. Sasco,et al.  Tobacco use and its determinants in HIV-infected patients on antiretroviral therapy in West African countries. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[11]  D. Wild,et al.  A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials , 2012, PharmacoEconomics.

[12]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[13]  A. Wu,et al.  Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. , 1998, Medical care.

[14]  P. Braitstein,et al.  Sustainability of First-Line Antiretroviral Regimens: Findings From a Large HIV Treatment Program in Western Kenya , 2010, Journal of acquired immune deficiency syndromes.

[15]  J. Jelsma,et al.  An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART , 2005, AIDS care.

[16]  F. Lert,et al.  Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study , 2007, AIDS.

[17]  E. Wouters,et al.  Physical and emotional health outcomes after 12 months of public-sector antiretroviral treatment in the Free State Province of South Africa: a longitudinal study using structural equation modelling , 2009, BMC public health.

[18]  A. Fontaine,et al.  Physicians' recognition of the symptoms experienced by HIV patients: how reliable? , 1999, Journal of pain and symptom management.

[19]  Sunitha C. Srinivas,et al.  Healthcare providers’ experiences with adverse drug reactions and adherence challenges in antiretroviral therapy of HIV patients in the Eastern Cape Province, South Africa , 2012, European Journal of Clinical Pharmacology.

[20]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[21]  A. Wu,et al.  Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies , 2013, Health and Quality of Life Outcomes.

[22]  J. Moatti,et al.  Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries , 2008, AIDS.

[23]  Paige L. Williams,et al.  Gender differences in health-related quality of life in patients with HIV/AIDS , 2005, Quality of Life Research.

[24]  L. Myer,et al.  Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme , 2009, Journal of the International AIDS Society.

[25]  M Sullivan,et al.  The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[26]  F. Dabis,et al.  Low retention of HIV‐infected patients on antiretroviral therapy in 11 clinical centres in West Africa , 2010, Tropical medicine & international health : TM & IH.

[27]  I. Wilson,et al.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. , 1995, JAMA.

[28]  A. Wu,et al.  Development and validation of a self-completed HIV symptom index. , 2001, Journal of clinical epidemiology.

[29]  M Sullivan,et al.  The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[30]  F. Dabis,et al.  Pharmacovigilance for antiretroviral drugs in Africa: lessons from a study in Abidjan, Cote d'Ivoire , 2011, Pharmacoepidemiology and drug safety.

[31]  C. Katlama,et al.  Health‐Related Quality of Life After 1 Year of Highly Active Antiretroviral Therapy , 2003, Journal of acquired immune deficiency syndromes.

[32]  J. Moatti,et al.  Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. , 2002, Social science & medicine.

[33]  R. Wood,et al.  The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population , 1996, Quality of Life Research.

[34]  S. Mallal,et al.  HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection , 2013, Health and Quality of Life Outcomes.

[35]  T. F. Rinke de Wit,et al.  Implementation of an Antiretroviral Access Program for HIV-1-Infected Individuals in Resource-Limited Settings: Clinical Results From 4 African Countries , 2007, Journal of acquired immune deficiency syndromes.

[36]  A. Wu,et al.  Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  K. Oshikoya,et al.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria , 2009, BMC clinical pharmacology.